CIK 0001832038
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Invivyd, Inc.
Sign in to watch- Ticker
- IVVD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851403134
- Phone
- +1 781-819-0080
- Business address
- 205 CHURCH STREET, NEW HAVEN, CT
- Former names
- Adagio Therapeutics, Inc.
- 4 Planned sale Chief Legal Officer, Secretary sold 67,710 shares at an average $1.56 ($105,581)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 50,000 shares at $2.50 ($125,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Commercial Officer sold 49,656 shares at an average $0.60 ($29,808)
- 4 Planned sale Chief Financial Officer sold 49,656 shares at an average $0.60 ($29,808)
- 4 Planned sale Chief Human Resources Officer sold 49,656 shares at an average $0.60 ($29,808)
- 4 Planned sale Chief Legal Officer, Secretary sold 82,754 shares at an average $0.60 ($49,677)
- 4 Planned sale Chief Scientific Officer sold 45,932 shares at an average $0.60 ($27,573)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 9 · 165 filings